Elite Pharmaceuticals Inc /NV/

Elite Pharmaceuticals Inc /NV/ appears in our data through filings on Elite Pharmaceuticals Inc shares, published by SEC (Form 4). The record holds 2 filings, for trades running from 22 August 2025 to 25 August 2025.

Every open-market trade on record is a sale: 1 sale worth €226k. Besides market trades, the filings include 1 option exercise.

The newest entry dates from 26 August 2025: an option exercise of €65k, in Elite Pharmaceuticals Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.